Inducible RNAi system and its application in novel therapeutics

References

• The ENCODE Project Consortium. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57–74
   PubMed Web of Science ®Google Scholar
• Aagaard L, Rossi JJ. (2007). RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev, 59, 75–86
   PubMed Web of Science ®Google Scholar
• Ait-ali T, Rands C, Harberd NP. (2003). Flexible control of plant architecture and yield via switchable expression of Arabidopsis gai. Plant Biotechnol J, 1, 337–43
   PubMed Web of Science ®Google Scholar
• Almeida R, Allshire RC. (2005). RNA silencing and genome regulation. Trends Cell Biol, 15, 251–8
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol, 29, 341–5
   PubMed Web of Science ®Google Scholar
• Amar L, Desclaux M, Faucon-Biguet N, et al. (2006). Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucl Acids Res, 34, e37
   PubMed Web of Science ®Google Scholar
• Azria D, Riou O, Rebillard X, et al. (2013). Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trial. Int J Radiat Oncol Biol Phys, 88, 853–9
   Google Scholar
• Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281–97
   PubMed Web of Science ®Google Scholar
• Belizario JE, Akamini P, Wolf P, et al. (2012). New routes for transgenesis of the mouse. J Appl Genet, 53, 295–315
   PubMed Web of Science ®Google Scholar
• Birney E, Stamatoyannopoulos JA, Dutta A, et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799–816
   PubMed Web of Science ®Google Scholar
• Boden D, Pusch O, Lee F, et al. (2003). Promoter choice affects the potency of HIV-1 specific RNA interference. Nucl Acids Res, 31, 5033–8
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550–3
   PubMed Web of Science ®Google Scholar
• Budker VG, Subbotin VM, Budker T, et al. (2006). Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies. J Gen Med, 8, 874–88
   PubMed Web of Science ®Google Scholar
• Calin GA, Liu CG, Ferracin M, et al. (2007). Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell, 12, 215–29
   PubMed Web of Science ®Google Scholar
• Castanotto D, Rossi JJ. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature, 457, 426–33
   PubMed Web of Science ®Google Scholar
• Cave E, Weinberg MS, Cilliers T, et al. (2006). Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag. AIDS Res Hum Retrovir, 22, 401–10
   PubMed Web of Science ®Google Scholar
• Chao JS, Chao CC, Chang CL, et al. (2012). Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline. Mol Biotechnol, 51, 240–6
   PubMed Web of Science ®Google Scholar
• Chen Y, Stamatoyannopoulos G, Song CZ. (2003). Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res, 63, 4801–4
   PubMed Web of Science ®Google Scholar
• Christoph T, Bahrenberg G, De Vry J, et al. (2008). Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice. Mol Cell Neurosci, 37, 579–89
   PubMed Web of Science ®Google Scholar
• Collis SJ, Swartz MJ, Nelson WG, DeWeese TL. (2003). Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res, 63, 1550–4
   PubMed Web of Science ®Google Scholar
• Corridon PR, Rhodes GJ, Leonard EC, et al. (2013). A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors. Am J Physiol Renal Physiol, 304, F1217–29
   PubMed Web of Science ®Google Scholar
• Czauderna F, Santel A, Hinz M, et al. (2003). Inducible shRNA expression for application in a prostate cancer mouse model. Nucl Acid Res, 31, e127
   PubMed Web of Science ®Google Scholar
• Daughters RS, Tuttle DL, Gao W, et al. (2009). RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet, 5, e1000600
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH, et al. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464, 1067–70
   PubMed Web of Science ®Google Scholar
• De Gendt K, Verhoeven G. (2012). Tissue- and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice. Mol Cell Endocrinol, 352, 13–25
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Gen Res, 22, 1775–89
   PubMed Web of Science ®Google Scholar
• DeVincenzo J, Cehelsky JE, Alvarez R, et al. (2008). Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res, 77, 225–31
   PubMed Web of Science ®Google Scholar
• Devroe E, Silver PA. (2002). Retrovirus-delivered siRNA. BMC Biotechnol, 2, 15
   PubMedGoogle Scholar
• Elbashir SM, Harborth J, Lendeckel W, et al. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494–8
   PubMed Web of Science ®Google Scholar
• Faghihi MA, Modarresi F, Khalil AM, et al. (2008). Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med, 14, 723–30
   PubMed Web of Science ®Google Scholar
• Farh KK, Grimson A, Jan C, et al. (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817–21
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, et al. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806–11
   PubMed Web of Science ®Google Scholar
• Gatz C, Frohberg C, Wendenburg R. (1992). Stringent repression and homogeneous de-repression by tetracycline of a modified CaMV 35S promoter in intact transgenic tobacco plants. Plant J: Cell Mol Biol, 2, 397–404
   PubMed Web of Science ®Google Scholar
• Gnyszka A, Jastrzebski Z, Flis S. (2013). DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res, 33, 2989–96
   PubMed Web of Science ®Google Scholar
• Gomez-Martinez M, Schmitz D, Hergovich A. (2013). Generation of stable human cell lines with Tetracycline-inducible (Tet-on) shRNA or cDNA expression. J Vis Exp, 73, e50171
   Google Scholar
• Gonzalez-Gonzalez C, Garcia-Hoyos M, Hernaez Calzon R, et al. (2012). Microdeletion found by array-CGH in girl with blepharophimosis syndrome and apparently balanced translocation t(3;15)(q23;q25). Ophthal Genet, 33, 107–10
   PubMed Web of Science ®Google Scholar
• Gossen M, Bujard H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA, 89, 5547–51
   PubMed Web of Science ®Google Scholar
• Gossen M, Freundlieb S, Bender G, et al. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766–9
   PubMed Web of Science ®Google Scholar
• Grimm D, Streetz KL, Jopling CL, et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537–41
   PubMed Web of Science ®Google Scholar
• Groner AC, Tschopp P, Challet L, et al. (2012). The Kruppel-associated box repressor domain can induce reversible heterochromatization of a mouse locus in vivo. J Biol Chem, 287, 25361–9
   PubMed Web of Science ®Google Scholar
• Guffanti A, Iacono M, Pelucchi P, et al. (2009). A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genom, 10, 163
   PubMed Web of Science ®Google Scholar
• Gupta S, Schoer RA, Egan JE, et al. (2004). Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA, 101, 1927–32
   PubMed Web of Science ®Google Scholar
• Han P, Li W, Lin CH, et al. (2014). A long noncoding RNA protects the heart from pathological hypertrophy. Nature, 514, 102–6
   PubMed Web of Science ®Google Scholar
• Hannon GJ, Rossi JJ. (2004). Unlocking the potential of the human genome with RNA interference. Nature, 431, 371–8
   PubMed Web of Science ®Google Scholar
• Heitz F, Johansson T, Baumgartel K, et al. (2014). Heritable and inducible gene knockdown in astrocytes or neurons in vivo by a combined lentiviral and RNAi approach. Front Cell Neurosci, 8, 62
   PubMed Web of Science ®Google Scholar
• Hickey MJ, Kasahara N, Mueller BM, Kruse CA. (2013). Combining cellular and gene therapy approaches for treatment of intracranial tumors. Oncoimmunology, 2, e25989
   PubMed Web of Science ®Google Scholar
• Hidaka M, Takatsuki M, Soyama A, et al. (2013). [I. Diagnosis and treatment for hepatoma]. Gan to kagaku ryoho. Canc Chemother, 40, 1297–300
   PubMedGoogle Scholar
• Hiltunen MO, Turunen MP, Yla-Herttuala S. (2002). Gene therapy methods in cardiovascular diseases. Meth Enzymol, 346, 311–20
   PubMed Web of Science ®Google Scholar
• Hornung V, Guenthner-Biller M, Bourquin C, et al. (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med, 11, 263–70
   PubMed Web of Science ®Google Scholar
• Jiang N, Du G, Tobias E, et al. (2013). Dietary and genetic effects on age-related loss of gene silencing reveal epigenetic plasticity of chromatin repression during aging. Aging, 5, 813–24
   PubMedGoogle Scholar
• Johnsen KB, Gudbergsson JM, Skov MN, et al. (2014). A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta, 1846, 75–87
   PubMed Web of Science ®Google Scholar
• Johnson SM, Grosshans H, Shingara J, et al. (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635–47
   PubMed Web of Science ®Google Scholar
• Kämper MR, Gohla G, Schlüter G. (2002). A novel positive tetracycline-dependent transactivator (rtTA) variant with reduced background activity and enhanced activation potential. FEBS Lett, 517, 115–20
   PubMed Web of Science ®Google Scholar
• Kappel S, Matthess Y, Zimmer B, et al. (2006a). Tumor inhibition by genomically integrated inducible RNAi-cassettes. Nucl Acid Res, 34, 4527–36
   PubMed Web of Science ®Google Scholar
• Kappel S, Matthess Y, Zimmer B, et al. (2006b). Tumor inhibition by genomically integrated inducible RNAi-cassettes. Nucl Acid Res, 34, 4527–36
   PubMed Web of Science ®Google Scholar
• Kaszubiak A, Kupstat A, Muller U, et al. (2007). Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1. Biochem Biophys Res Commun, 357, 295–301
   PubMed Web of Science ®Google Scholar
• Kim DH, Rossi JJ. (2007). Strategies for silencing human disease using RNA interference. Nat Rev Genet, 8, 173–84
   PubMed Web of Science ®Google Scholar
• Kotnik K, Popova E, Todiras M, et al. (2009). Inducible transgenic rat model for diabetes mellitus based on shRNA-mediated gene knockdown. PloS One, 4, e5124
   PubMed Web of Science ®Google Scholar
• Krebs CJ, Zhang D, Yin L, Robins DM. (2014). The KRAB zinc finger protein rsl1 modulates sex-biased gene expression in liver and adipose tissue to maintain metabolic homeostasis. Mol Cell Biol, 34, 221–32
   PubMed Web of Science ®Google Scholar
• Kumar LD, Clarke AR. (2007). Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Adv Drug Deliv Rev, 59, 87–100
   PubMed Web of Science ®Google Scholar
• Kunigal S, Lakka SS, Sodadasu PK, et al. (2009). Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer. Int J Oncol, 34, 1209–20
   PubMed Web of Science ®Google Scholar
• Leachman SA, Hickerson RP, Schwartz ME, et al. (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Therap, 18, 442–6
   PubMed Web of Science ®Google Scholar
• Leng Q, Woodle MC, Lu PY, Mixson AJ. (2009). Advances in systemic siRNA delivery. Drugs Future, 34, 721
   PubMed Web of Science ®Google Scholar
• Li L, Lin X, Staver M, et al. (2005). Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res, 65, 7249–8
   PubMed Web of Science ®Google Scholar
• Lim LP, Lau NC, Garrett-Engele P, et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769–73
   PubMed Web of Science ®Google Scholar
• Lin R, Maeda S, Liu C, et al. (2007). A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene, 26, 851–58
   PubMed Web of Science ®Google Scholar
• Lin X, Ruan X, Anderson MG, et al. (2005). siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucl Acid Res, 33, 4527–35
   PubMed Web of Science ®Google Scholar
• Liu Z, Winters M, Holodniy M, Dai H. (2007). siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl, 46, 2023–7
   PubMed Web of Science ®Google Scholar
• Lizcano F, Garcia J. (2012). Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets. Pharmaceuticals (Basel), 5, 963–90
   PubMedGoogle Scholar
• Marques JT, Williams BR. (2005). Activation of the mammalian immune system by siRNAs. Nat Biotechnol, 23, 1399–405
   PubMed Web of Science ®Google Scholar
• Masclaux F, Charpenteau M, Takahashi T, et al. (2004). Gene silencing using a heat-inducible RNAi system in Arabidopsis. Biochem Biophys Res Commun, 321, 364–9
   PubMed Web of Science ®Google Scholar
• Matsukura S, Jones PA, Takai D. (2003). Establishment of conditional vectors for hairpin siRNA knockdowns. Nucl Acid Res, 31, e77
   PubMed Web of Science ®Google Scholar
• Matthess Y, Kappel S, Spankuch B, et al. (2005). Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene, 24, 2973–80
   PubMed Web of Science ®Google Scholar
• McCaffrey AP, Meuse L, Pham TT, et al. (2002). RNA interference in adult mice. Nature, 418, 38–9
   PubMed Web of Science ®Google Scholar
• Meerbrey KL, Hu G, Kessler JD, et al. (2011). The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA, 108, 3665–70
   PubMed Web of Science ®Google Scholar
• Meissner A, Jaenisch R. (2006). Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature, 439, 212–15
   PubMed Web of Science ®Google Scholar
• Mett VL, Lochhead LP, Reynolds PH. (1993). Copper-controllable gene expression system for whole plants. Proc Nalt Acad Sci USA, 90, 4567–71
   PubMed Web of Science ®Google Scholar
• Mus E, Hof PR, Tiedge H. (2007). Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Nalt Acad Sci USA, 104, 10679–84
   PubMed Web of Science ®Google Scholar
• Ngo VN, Davis RE, Lamy L, et al. (2006). A loss-of-function RNA interference screen for molecular targets in cancer. Nature, 441, 106–10
   PubMed Web of Science ®Google Scholar
• Nicholson LJ, Philippe M, Paine AJ, et al. (2005). RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Therap, 11, 638–44
   PubMed Web of Science ®Google Scholar
• Nie L, Das Thakur M, Wang Y, et al. (2010). Regulation of U6 promoter activity by transcriptional interference in viral vector-based RNAi. Genom Proteom Bioinformat, 8, 170–9
   PubMedGoogle Scholar
• Nieth C, Priebsch A, Stege A, Lage H. (2003). Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett, 545, 144–50
   PubMed Web of Science ®Google Scholar
• Ohkawa J, Taira K. (2000). Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter. Hum Gene Therapy, 11, 577–85
   PubMed Web of Science ®Google Scholar
• Pankiewicz R, Karlen Y, Imhof MO, Mermod N. (2005). Reversal of the silencing of tetracycline-controlled genes requires the coordinate action of distinctly acting transcription factors. J Gene Med, 7, 117–32
   PubMed Web of Science ®Google Scholar
• Paproski RJ, Forbrich AE, Wachowicz K, et al. (2011). Tyrosinase as a dual reporter gene for both photoacoustic and magnetic resonance imaging. Biomed Optics Express, 2, 771–80
   PubMed Web of Science ®Google Scholar
• Pastori C, Peschansky VJ, Barbouth D, et al. (2014). Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome. Human Genet, 133, 59–67
   PubMed Web of Science ®Google Scholar
• Pauli A, Rinn JL, Schier AF. (2011). Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet, 12, 136–49
   PubMed Web of Science ®Google Scholar
• Peacock RW, Sullivan KA, Wang CL. (2012). Tetracycline-regulated expression implemented through transcriptional activation combined with proximal and distal repression. ACS Synthet Biol, 1, 156–62
   PubMed Web of Science ®Google Scholar
• Pickl JM, Heckmann D, Ratz L, et al. (2014). Novel RNA markers in prostate cancer: functional considerations and clinical translation. BioMed Res Int, 2014, 765207
   PubMed Web of Science ®Google Scholar
• Pluta K, Diehl W, Zhang XY, et al. (2007). Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study. BMC Biotechnol, 7, 41
   PubMed Web of Science ®Google Scholar
• Pluta K, Luce MJ, Bao L, et al. (2005). Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gen Med, 7, 803–17
   PubMed Web of Science ®Google Scholar
• Ponting CP, Belgard TG. (2010). Transcribed dark matter: meaning or myth? Hum Mol Genet, 19, R162–8
   PubMed Web of Science ®Google Scholar
• Qi P, Du X. (2013). The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol, 26, 155–65
   PubMed Web of Science ®Google Scholar
• Ren XL, Xu YM, Bao W, et al. (2009). Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu. Canc Lett, 281, 134–43
   PubMed Web of Science ®Google Scholar
• Schiedner G, Morral N, Parks RJ, et al. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet, 18, 180–3
   PubMed Web of Science ®Google Scholar
• Seibler J, Kleinridders A, Kuter-Luks B, et al. (2007). Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucl Acid Res, 35, e54
   PubMed Web of Science ®Google Scholar
• Shen C, Buck AK, Liu X, et al. (2003). Gene silencing by adenovirus-delivered siRNA. FEBS Lett, 539, 111–14
   PubMed Web of Science ®Google Scholar
• Sheng L, Xiong M, Li C, Meng X. (2013). Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM. Pathol Oncol Res, 20, 541–8
   Google Scholar
• Shimamura Y, Ishii N, Nakano K, et al. (2013). Repeat endoscopic submucosal dissection for recurrent gastric cancers after endoscopic submucosal dissection. World J Gastrointest Endos, 5, 600–4
   PubMedGoogle Scholar
• Sigl R, Ploner C, Shivalingaiah G, et al. (2014). Development of a multipurpose GATEWAY-Based lentiviral tetracycline-regulated conditional RNAi system (GLTR). PloS One, 9, e97764
   PubMed Web of Science ®Google Scholar
• Sledz CA, Holko M, de Veer MJ, et al. (2003). Activation of the interferon system by short-interfering RNAs. Nat Cell Biol, 5, 834–9
   PubMed Web of Science ®Google Scholar
• Sledz CA, Williams BR. (2004). RNA interference and double-stranded-RNA-activated pathways. Biochem Soc Trans, 32, 952–6
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Bata-Csorgo Z, Pivarcsi A, et al. (2005). Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. J Biol Chem, 280, 24159–67
   PubMed Web of Science ®Google Scholar
• Stark GR, Kerr IM, Williams BR, et al. (1998). How cells respond to interferons. Ann Rev Biochem, 67, 227–64
   PubMed Web of Science ®Google Scholar
• Stedt H, Samaranayake H, Pikkarainen J, et al. (2013). Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide. Gene Therap, 20, 1165–71
   PubMed Web of Science ®Google Scholar
• Stolarov J, Chang K, Reiner A, et al. (2001). Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc Nalt Acad Sci USA, 98, 13043–8
   PubMed Web of Science ®Google Scholar
• Stovall DB, Wan M, Zhang Q, et al. (2012). DNA vector-based RNA interference to study gene function in cancer. J Vis Exp, 64, e4129
   Google Scholar
• Sun Y, Chen X, Xiao D. (2007). Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim Biophys Sinica, 39, 235–46
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yan IK, Kogure T, et al. (2014). Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio, 4, 458–67
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nishikawa M, Takakura Y. (2009). Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Adv Drug Deliv Rev, 61, 760–6
   PubMed Web of Science ®Google Scholar
• Tsai MC, Spitale RC, Chang HY. (2011). Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res, 71, 3–7
   PubMed Web of Science ®Google Scholar
• Tummalapalli P, Gondi CS, Dinh DH, et al. (2007). RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. Int J Oncol, 31, 5–17
   PubMed Web of Science ®Google Scholar
• Tuschl T. (2002). Expanding small RNA interference. Nat Biotechnol, 20, 446–8
   PubMed Web of Science ®Google Scholar
• Unwalla HJ, Li MJ, Kim JD, et al. (2004). Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat Biotechnol, 22, 1573–8
   PubMed Web of Science ®Google Scholar
• Verma IM, Somia N. (1997). Gene therapy – promises, problems and prospects. Nature, 389, 239–42
   PubMed Web of Science ®Google Scholar
• Visel A, Zhu Y, May D, et al. (2010). Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature, 464, 409–12
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang HY. (2011). Molecular mechanisms of long noncoding RNAs. Mol Cell, 43, 904–14
   PubMed Web of Science ®Google Scholar
• Wang W, Peng H, Li J, et al. (2013). Controllable inhibition of hepatitis B virus replication by a DR1-targeting short hairpin RNA (shRNA) expressed from a DOX-inducible lentiviral vector. Virus Gene, 46, 393–403
   PubMed Web of Science ®Google Scholar
• Wiederschain D, Wee S, Chen L, et al. (2009). Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle, 8, 498–504
   PubMed Web of Science ®Google Scholar
• Wiznerowicz M, Szulc J, Trono D. (2006). Tuning silence: conditional systems for RNA interference. Nat Meth, 3, 682–8
   PubMed Web of Science ®Google Scholar
• Wiznerowicz M, Trono D. (2003). Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol, 77, 8957–61
   PubMed Web of Science ®Google Scholar
• Wu RH, Cheng TL, Lo SR, et al. (2007). A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells. J Gene Med, 9, 620–34
   PubMed Web of Science ®Google Scholar
• Yan S, Fu Q, Zhou Y, et al. (2012). High levels of gene expression in the hepatocytes of adult mice, neonatal mice and tree shrews via retro-orbital sinus hydrodynamic injections of naked plasmid DNA. J Control Rel, 161, 763–71
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. (2014). LncRNA: a link between RNA and cancer. Biochim Biophys Acta, 1839, 1097–109
   PubMed Web of Science ®Google Scholar
• Yi R, Doehle BP, Qin Y, et al. (2005). Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA, 11, 220–6
   PubMed Web of Science ®Google Scholar
• Yin D, He X, Zhang E, et al. (2014). Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol, 31, 253
   PubMed Web of Science ®Google Scholar
• Zamore PD, Tuschl T, Sharp PA, Bartel DP. (2000). RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25–33
   PubMed Web of Science ®Google Scholar
• Zhang H, Kolb FA, Jaskiewicz L, et al. (2004). Single processing center models for human Dicer and bacterial RNase III. Cell, 118, 57–68
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao J, Jiang WJ, et al. (2012). Conditional gene manipulation: cre-ating a new biological era. J Zhejiang Univ Sci B, 13, 511–24
   PubMed Web of Science ®Google Scholar